194 related articles for article (PubMed ID: 33230243)
1. Reciprocal REGγ-mTORC1 regulation promotes glycolytic metabolism in hepatocellular carcinoma.
Yao L; Xuan Y; Zhang H; Yang B; Ma X; Wang T; Meng T; Sun W; Wei H; Ma X; Moses R; Xiao J; Zhang P; Ge C; Li J; Li L; Li X; Li J; Zhang B
Oncogene; 2021 Jan; 40(3):677-692. PubMed ID: 33230243
[TBL] [Abstract][Full Text] [Related]
2. Persistent mTORC1 activation via Depdc5 deletion results in spontaneous hepatocellular carcinoma but does not exacerbate carcinogen- and high-fat diet-induced hepatic carcinogenesis in mice.
Xu L; Yang C; Wang J; Li Z; Huang R; Ma H; Ma J; Wang Q; Xiong X
Biochem Biophys Res Commun; 2021 Nov; 578():142-149. PubMed ID: 34562654
[TBL] [Abstract][Full Text] [Related]
3. The REGγ proteasome regulates hepatic lipid metabolism through inhibition of autophagy.
Dong S; Jia C; Zhang S; Fan G; Li Y; Shan P; Sun L; Xiao W; Li L; Zheng Y; Liu J; Wei H; Hu C; Zhang W; Chin YE; Zhai Q; Li Q; Liu J; Jia F; Mo Q; Edwards DP; Huang S; Chan L; O'Malley BW; Li X; Wang C
Cell Metab; 2013 Sep; 18(3):380-91. PubMed ID: 24011073
[TBL] [Abstract][Full Text] [Related]
4. BUB1B promotes hepatocellular carcinoma progression via activation of the mTORC1 signaling pathway.
Qiu J; Zhang S; Wang P; Wang H; Sha B; Peng H; Ju Z; Rao J; Lu L
Cancer Med; 2020 Nov; 9(21):8159-8172. PubMed ID: 32977361
[TBL] [Abstract][Full Text] [Related]
5. The proteasome activator REGγ counteracts immunoproteasome expression and autoimmunity.
Yao L; Zhou L; Xuan Y; Zhang P; Wang X; Wang T; Meng T; Xue Y; Ma X; Shah AS; Shang S; Ma X; Xie W; Wang H; Fu Q; Xia Y; Moses RE; Wang H; Li L; Xiao J; Zhang B; Li X
J Autoimmun; 2019 Sep; 103():102282. PubMed ID: 31171475
[TBL] [Abstract][Full Text] [Related]
6. Mitochondrial GCN5L1 regulates glutaminase acetylation and hepatocellular carcinoma.
Zhang T; Cui Y; Wu Y; Meng J; Han L; Zhang J; Zhang C; Yang C; Chen L; Bai X; Zhang K; Wu K; Sack MN; Wang L; Zhu L
Clin Transl Med; 2022 May; 12(5):e852. PubMed ID: 35538890
[TBL] [Abstract][Full Text] [Related]
7. Differential regulation of the REGγ-proteasome pathway by p53/TGF-β signalling and mutant p53 in cancer cells.
Ali A; Wang Z; Fu J; Ji L; Liu J; Li L; Wang H; Chen J; Caulin C; Myers JN; Zhang P; Xiao J; Zhang B; Li X
Nat Commun; 2013; 4():2667. PubMed ID: 24157709
[TBL] [Abstract][Full Text] [Related]
8. The REGγ inhibitor NIP30 increases sensitivity to chemotherapy in p53-deficient tumor cells.
Gao X; Wang Q; Wang Y; Liu J; Liu S; Liu J; Zhou X; Zhou L; Chen H; Pan L; Chen J; Wang D; Zhang Q; Shen S; Xiao Y; Wu Z; Cheng Y; Chen G; Kubra S; Qin J; Huang L; Zhang P; Wang C; Moses RE; Lonard DM; Malley BWO; Fares F; Zhang B; Li X; Li L; Xiao J
Nat Commun; 2020 Aug; 11(1):3904. PubMed ID: 32764536
[TBL] [Abstract][Full Text] [Related]
9. Nucleophosmin (NPM1/B23) interacts with activating transcription factor 5 (ATF5) protein and promotes proteasome- and caspase-dependent ATF5 degradation in hepatocellular carcinoma cells.
Liu X; Liu D; Qian D; Dai J; An Y; Jiang S; Stanley B; Yang J; Wang B; Liu X; Liu DX
J Biol Chem; 2012 Jun; 287(23):19599-609. PubMed ID: 22528486
[TBL] [Abstract][Full Text] [Related]
10. REGγ deficiency suppresses tumor progression via stabilizing CK1ε in renal cell carcinoma.
Chen S; Wang Q; Wang L; Chen H; Gao X; Gong D; Ma J; Kubra S; Yao X; Li X; Li L; Zhai W; Zheng J
Cell Death Dis; 2018 May; 9(6):627. PubMed ID: 29795381
[TBL] [Abstract][Full Text] [Related]
11. REGgamma modulates p53 activity by regulating its cellular localization.
Liu J; Yu G; Zhao Y; Zhao D; Wang Y; Wang L; Liu J; Li L; Zeng Y; Dang Y; Wang C; Gao G; Long W; Lonard DM; Qiao S; Tsai MJ; Zhang B; Luo H; Li X
J Cell Sci; 2010 Dec; 123(Pt 23):4076-84. PubMed ID: 21084564
[TBL] [Abstract][Full Text] [Related]
12. REGgamma proteasome activator is involved in the maintenance of chromosomal stability.
Zannini L; Lecis D; Buscemi G; Carlessi L; Gasparini P; Fontanella E; Lisanti S; Barton L; Delia D
Cell Cycle; 2008 Feb; 7(4):504-12. PubMed ID: 18235248
[TBL] [Abstract][Full Text] [Related]
13. Hippocalcin-Like 1 blunts liver lipid metabolism to suppress tumorigenesis via directly targeting RUVBL1-mTOR signaling.
Chen T; Yuan Z; Lei Z; Duan J; Xue J; Lu T; Yan G; Zhang L; Liu Y; Li Q; Zhang Y
Theranostics; 2022; 12(17):7450-7464. PubMed ID: 36438486
[No Abstract] [Full Text] [Related]
14. PKA turnover by the REGγ-proteasome modulates FoxO1 cellular activity and VEGF-induced angiogenesis.
Liu S; Lai L; Zuo Q; Dai F; Wu L; Wang Y; Zhou Q; Liu J; Liu J; Li L; Lin Q; Creighton CJ; Costello MG; Huang S; Jia C; Liao L; Luo H; Fu J; Liu M; Yi Z; Xiao J; Li X
J Mol Cell Cardiol; 2014 Jul; 72():28-38. PubMed ID: 24560667
[TBL] [Abstract][Full Text] [Related]
15. Dampened VEPH1 activates mTORC1 signaling by weakening the TSC1/TSC2 association in hepatocellular carcinoma.
Dong P; Wang X; Liu L; Tang W; Ma L; Zeng W; Sun S; Zhang L; Zhang N; Shen X; Janssen HLA; Dong L; Zhang S; Chen S
J Hepatol; 2020 Dec; 73(6):1446-1459. PubMed ID: 32610114
[TBL] [Abstract][Full Text] [Related]
16. REGγ is associated with multiple oncogenic pathways in human cancers.
He J; Cui L; Zeng Y; Wang G; Zhou P; Yang Y; Ji L; Zhao Y; Chen J; Wang Z; Shi T; Zhang P; Chen R; Li X
BMC Cancer; 2012 Feb; 12():75. PubMed ID: 22361172
[TBL] [Abstract][Full Text] [Related]
17. An inflammatory-CCRK circuitry drives mTORC1-dependent metabolic and immunosuppressive reprogramming in obesity-associated hepatocellular carcinoma.
Sun H; Yang W; Tian Y; Zeng X; Zhou J; Mok MTS; Tang W; Feng Y; Xu L; Chan AWH; Tong JH; Cheung YS; Lai PBS; Wang HKS; Tsang SW; Chow KL; Hu M; Liu R; Huang L; Yang B; Yang P; To KF; Sung JJY; Wong GLH; Wong VWS; Cheng ASL
Nat Commun; 2018 Dec; 9(1):5214. PubMed ID: 30523261
[TBL] [Abstract][Full Text] [Related]
18. Regulation of c-Myc protein stability by proteasome activator REGγ.
Li S; Jiang C; Pan J; Wang X; Jin J; Zhao L; Pan W; Liao G; Cai X; Li X; Xiao J; Jiang J; Wang P
Cell Death Differ; 2015 Jun; 22(6):1000-11. PubMed ID: 25412630
[TBL] [Abstract][Full Text] [Related]
19. Upregulation of GSK3β Contributes to Brain Disorders in Elderly REGγ-knockout Mice.
Lv Y; Meng B; Dong H; Jing T; Wu N; Yang Y; Huang L; Moses RE; O'Malley BW; Mei B; Li X
Neuropsychopharmacology; 2016 Apr; 41(5):1340-9. PubMed ID: 26370326
[TBL] [Abstract][Full Text] [Related]
20. Ubiquitin- and ATP-independent proteolytic turnover of p21 by the REGgamma-proteasome pathway.
Li X; Amazit L; Long W; Lonard DM; Monaco JJ; O'Malley BW
Mol Cell; 2007 Jun; 26(6):831-42. PubMed ID: 17588518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
